Kansas City Based Health Care Startup Buys Digital Therapeutics Company Focused on Alzheimer's and Dementia.

MANews-(C)2009-2022

US-based medical technology company Telememory Holding Corp., the makers of MoodSpark, has purchased digital therapeutics firm Dthera Sciences, the company said.

Dthera Sciences develops quality of life therapies for those suffering from cognitive decline.

The deal brings a large intellectual property portfolio under the MoodSpark banner including an FDA Breakthrough device designation, several patents, a technology platform, and clinical pilot research.

Dthera Sciences developed a system for treating acute episodes of anxiety, agitation and depression in elderly patients suffering from neurodegenerative diseases including Alzheimer's and dementia.

The system delivers digital reminiscence therapy, a common behavioral intervention that involves presenting familiar pictures, music, and other materials to help patients remember past experiences.

The system is designed to enable more efficient delivery of the therapy to more patients.

MoodSpark is a digital companion that detects grief and uplifts with memories, conversations and video visits from friends, family, and caregivers.

This robotic assistive technology is purpose-built to provide digitally enhanced support and companion care for the elderly.

Digital...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT